Sector
PharmaceuticalsOpen
₹1,960Prev. Close
₹1,972.45Turnover(Lac.)
₹7,764.04Day's High
₹2,069Day's Low
₹1,94052 Week's High
₹2,023.952 Week's Low
₹1,004.45Book Value
₹299.41Face Value
₹10Mkt Cap (₹ Cr.)
8,355.34P/E
81.41EPS
24.23Divi. Yield
0.14Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 36.88 | 36.44 | 36.44 | 31.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 638.23 | 550.35 | 481.57 | 132.45 |
Net Worth | 675.11 | 586.79 | 518.01 | 163.95 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Revenue | 520.13 | 340.6 |
yoy growth (%) | 52.7 | |
Raw materials | -272.83 | -179.68 |
As % of sales | 52.45 | 52.75 |
Employee costs | -41.36 | -20.98 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Profit before tax | 91.45 | 71.72 |
Depreciation | -10.08 | -4.18 |
Tax paid | -19.5 | -17.72 |
Working capital | 186.55 | |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | 52.7 | |
Op profit growth | 31.13 | |
EBIT growth | 26.52 | |
Net profit growth | 33.23 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 717.47 | 616.73 | 520.14 | 340.61 | 239.64 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 717.47 | 616.73 | 520.14 | 340.61 | 239.64 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 7.49 | 4.32 | 2.76 | 1.38 | 2.84 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,803.6 | 157.42 | 4,33,991.71 | 863.29 | 0.75 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,811.25 | 94.22 | 1,56,497.71 | 430 | 0.51 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,601.2 | 30.22 | 1,27,967.54 | 1,178.16 | 0.82 | 3,969.86 | 360.74 |
Mankind Pharma Ltd MANKIND | 2,714.25 | 58.45 | 1,09,574.17 | 513.49 | 0 | 2,403.26 | 240.2 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,184.15 | 66.17 | 1,08,245.22 | 460 | 0.88 | 2,376 | 222.38 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director
Nareshbhai Ramjibhai Patel
Whole-time Director
Chetankumar Chhaganlal Vaghasia
Whole-time Director
Virendra Nath Mishra
Whole-time Director
Ram Mohan Rao Locande
Independent Non Exe. Director
Girikrishna Maniar
Independent Non Exe. Director
Hetal Gandhi
Independent Non Exe. Director
Richa M. Goyal
Independent Non Exe. Director
Anita Bandyopadhyay
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Ami Organics Ltd
Summary
Ami Organics Limited was initially formed as a partnership firm in the name of Ami Organics with effect from 03 January, 2004 at Surat, India. The Firm converted into a Private Limited Company under the name of Ami Organics Private Limited with a Certificate of Incorporation dated 12 June, 2007. Subsequently, the Company was converted into a Public Limited Company, following which the Companys name was changed to Ami Organics Limited, and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018.The Company is engaged in business of drugs intermediate chemicals and related activities. The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015. It increased warehouse capacity, equipped with modern infrastructure & a storage capacity of 1,050 MT of RM in 2017.The Company commenced its new Solvent Recovery Plant at Sachin in 2020. It acquired two units namely, the Ankleshwar and Jhagadia units from Gujarat Organics Limited (GOL) in 2021. The Company came out with an IPO which comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 370 crore by shareholders, mopped up with a total of Rs 570 crore through its public issue in September, 2021. The Company incorporated wholly
Read More
The Ami Organics Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹2041.15 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ami Organics Ltd is ₹8355.34 Cr. as of 05 Nov ‘24
The PE and PB ratios of Ami Organics Ltd is 81.41 and 6.71 as of 05 Nov ‘24
The 52-week high/low is the highest and lowest price at which a Ami Organics Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Ami Organics Ltd is ₹1004.45 and ₹2023.9 as of 05 Nov ‘24
Ami Organics Ltd's CAGR for 5 Years at 16.10%, 3 Years at 23.15%, 1 Year at 71.79%, 6 Month at 64.08%, 3 Month at 56.84% and 1 Month at 17.59%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice